Eam Investors, LLC Catalent, Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$47.45 - $58.05 $1.43 Million - $1.75 Million	-30,177 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$39.26 - $54.21 $1.18 Million - $1.64 Million	30,177 New	30,177 $1.64 Million
Q4 2017 Feb 12, 2018	SELL	$37.27 - $43.02 $2.28 Million - $2.63 Million	-61,148 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$33.75 - $41.67 $2.06 Million - $2.55 Million	61,148	61,148 $2.44 Million

484

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.